0001209191-15-059834.txt : 20150706
0001209191-15-059834.hdr.sgml : 20150703
20150706203623
ACCESSION NUMBER: 0001209191-15-059834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150706
DATE AS OF CHANGE: 20150706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTIME INC
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KINGSLEY ALFRED D
CENTRAL INDEX KEY: 0001229339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 15975041
MAIL ADDRESS:
STREET 1: 150 E 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-01
0
0000876343
BIOTIME INC
BTX
0001229339
KINGSLEY ALFRED D
150 E. 57TH STREET
NEW YORK
NY
10022
1
1
1
0
See Remarks
Common Shares, no par value
6038055
D
Common Shares, no par value
1506905
I
By Greenbelt Corp.
Common Shares, no par value
375351
I
By Greenway Partners, LP
Option to Purchase Common Shares
3.57
2015-07-01
4
A
0
50000
0.00
A
2020-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
3.11
2019-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
4.13
2018-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
4.60
2017-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
5.13
2016-06-30
Common Shares
50000
50000
D
Option to Purchase Common Shares
5.45
2015-08-09
Common Shares
50000
50000
D
Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
Will become exercisable in four equal quarterly installments based upon continued service on the board of directors.
Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014.
12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014.
12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013.
12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries.
/s/ Alfred D. Kingsley
2015-07-06